The CPH circus looks to be leaving town after Canadian listed PharmaCielo (PCLO.V) made an all-scrip AUD $122M offer to acquire Creso Pharma (CPH.ASX), which equated to AUD 0.63 per share when the deal was announced.
I’ve been hanging with the crypto kiddies for a few months now and sold the bulk of my holdings on the spike late last week. After the dust settled, I keyed the figures into my spreadsheet and started planning how I would spend the massive CAD 100 profit.
AUDIO: Equity Guru talks to ABC Radio’s NT Country Hour about Wayland Group’s (WAYL.C) Tropicann acquisition
Our recent article on the headwinds faced by Wayland Group’s (WAYL.C) acquisition of NT minnow Tropicann Pty Ltd caught the attention of NT Country Hour host Matt Brann.
The Wayland Group (WAYL.C), formerly known as Maricann, announced their entry onto the Australian cannabis scene on December 3, 2018 by agreeing to acquire 50.1% of privately held Tropicann for an initial sum of CAD $4.8 million and a further payment of CAD $24 million should certain milestones be met, including Tropicann obtaining a medicinal marijuana cultivation license.
Happy Thanksgiving to all you folks stateside (hey, you’ve already had your turn Canadians!). Thai’s celebrated Loy Krathong yesterday too, so it feels like the market is taking a backseat to festivities at the moment.
The footy season has wrapped up in Oz and things ended the way they should according to the laws of the Animal Kingdom. The Eagles beat the Magpies and the Roosters took care of the Bunnies.
We’re back with the fumble. Last week I was indisposed, apologies. A sexy nurse was slicing open my right arm and stuffing a camera through the artery all the way to my heart.